- Panel weighs delaying stage 2 of meaningful use
- The Food, Drug and EHR Administration?
- CMS checks systems to receive meaningful use data
- Panel endorses delay of stage 2 meaningful use to 2014
- Would meaningful use Stage 2 delay ignite ICD-10?
- Mostashari: No CIO should have to choose between ACO, MU
- HHS panelists start up 2013 meaningful use talks
- HHS panel says ease 2011 meaningful use tests
- Panel proposes reducing meaningful use measures
- HHS panel: CMS should reconsider discarded quality measures
- Health Information Exchange Toolkit
- New World Order: Effectively Securing Healthcare Data Through Secure Information Exchanges
- Accelerate Healthcare Reform with Information Technology
- Futureproofing Healthcare with Converged Medical Infrastructure
- Delivering the Future of Healthcare: Maintain Compliance, Improve Efficiency and Continuity of Care...Virtually Anywhere
An advisory panel is wrestling with competing visions of how bold to make measures for the next stage of meaningful use of electronic health records (EHRs). Time limitations underlie many of the tensions in deciding their path.
Vendors need time to develop new software and healthcare providers to install it and then report on quality measures to qualify for stage 2 incentives.
Further roiling the mix, the release last month of the proposed rule for establishing accountable care organizations (ACOs) adds another tension because it will also rely on reporting quality measures, according to members of the Health IT Policy Committee.
To accommodate time constraints for software development, committee members explored a phased-in approach that separates existing and new functionalities, according to Dr. Paul Tang, committee vice chair at the April 13 meeting. He is also chief medical information officer at the Palo Alto Medical Foundation.
[Related Q&A: The good, bad, and otherwise of ACO regs.]
In 2013, providers would fulfill core meaningful use objectives, increased performance thresholds and new quality measures. In 2014, requirements for new EHR functionalities would take effect. For example, the committee's meaningful use work group has proposed new objectives for electronic prescribing for discharge prescriptions, electronic clinical progress notes and patient-provider secure messaging.
Paul Egerman, a committee member and software entrepreneur, said the meaningful use process is already complicated without changing it again.
"It's disruptive to solo practitioners' practices to change things every year. We have to be aware of other things that are going on in the industry," he said, citing the approaching deadline for adopting ICD-10.
[Related: Should ICD-10 be delayed until 2016?]
If the committee only increases thresholds for the next stage of meaningful use, however, EHRs won't have the capabilities called for in ACOs and transitions of care, Tang said. "Stage 1 of meaningful use was getting data in a structured way; stage 2 is spreading it around," he said.
Deven McGraw, a committee member and director of the health privacy project at the Center for Democracy and Technology, offered that there should be alignment of meaningful use measures and those programs in the health reform law, such as accountable care organizations.
The proposed ACO rule from the Centers for Medicare and Medicaid Services incorporates quality measures, including some from the meaningful use program. The rule also has detailed some new measures related to sharing savings through coordinating patient care.
Continued on next page